Article
Nomogram to predict the EGFR mutation status in stage III-IV solid lung adenocarcinoma patients.
BMC medical imaging - 29 Sept 2025
Tang Wenjian, Kang Yuan, Lan Bo, Zhang Zhiqiang, Feng Jiawei, Li Feng, Zeng Xinyi, Zhong Junyuan, Luo Shuhua, Zhong Jianping
Abstract excerpt
BACKGROUND: To assess the clinical characteristics and CT findings associated with epidermal growth factor receptor (EGFR) mutation status in stage III-IV solid lung adenocarcinoma (LAD) patients. METHODS: In this retrospective study, stage III-IV solid LAD patients who underwent chest CT from January 2015 to July 2025 were included. Clinical characteristics and CT findings significantly associated with the EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
